Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori L Davis

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Psychopharmacology Bulletin|March 26, 2008
A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veteransLori L Davis, Charles Ward, Ann Rasmusson, et al.
European Journal of Psychotraumatology|November 13, 2016
What I have changed my mind about and whyRachel Yehuda, David Spiegel, Steven Southwick, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary studyLori L Davis, Michele E Jewell, Sandra Ambrose, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart reviewLori L Davis, Sandra M Ambrose, Jason M Newell, et al.
Nursing|October 11, 2021
COVID-19 and opioid use disorder: Expanding treatment access in rural settingsMercy Ngosa Mumba, Jessica Jaiswal, Natalia Langner-Smith, et al.
Journal of the American Psychiatric Nurses Association|October 12, 2021
Moderation Effects of Substance Use on Physical and Mental Well-Being in AdultsMercy Ngosa Mumba, Alexandra F Nancarrow, Jessica L Jaiswal, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran populationLori L Davis, Jonathan R T Davidson, L Charles Ward, et al.
Psychiatry Research|February 13, 2024
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderMegan E Parmenter, Seth Lederman, Frank W Weathers, et al.
Current Medical Research and Opinion|October 11, 2023
Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States - a retrospective claims studyLori L Davis, Annette Urganus, Patrick Gagnon-Sanschagrin, et al.
The Annals of Pharmacotherapy|August 19, 2003
Baclofen treatment for chronic posttraumatic stress disorderRoger G Drake, Lori L Davis, Marshall E Cates, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Psychopharmacology Bulletin|March 26, 2008
A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veteransLori L Davis, Charles Ward, Ann Rasmusson, et al.
European Journal of Psychotraumatology|November 13, 2016
What I have changed my mind about and whyRachel Yehuda, David Spiegel, Steven Southwick, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary studyLori L Davis, Michele E Jewell, Sandra Ambrose, et al.
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart reviewLori L Davis, Sandra M Ambrose, Jason M Newell, et al.
Nursing|October 11, 2021
COVID-19 and opioid use disorder: Expanding treatment access in rural settingsMercy Ngosa Mumba, Jessica Jaiswal, Natalia Langner-Smith, et al.
Journal of the American Psychiatric Nurses Association|October 12, 2021
Moderation Effects of Substance Use on Physical and Mental Well-Being in AdultsMercy Ngosa Mumba, Alexandra F Nancarrow, Jessica L Jaiswal, et al.
Journal of Clinical Psychopharmacology|January 22, 2008
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran populationLori L Davis, Jonathan R T Davidson, L Charles Ward, et al.
Psychiatry Research|February 13, 2024
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderMegan E Parmenter, Seth Lederman, Frank W Weathers, et al.
Current Medical Research and Opinion|October 11, 2023
Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States - a retrospective claims studyLori L Davis, Annette Urganus, Patrick Gagnon-Sanschagrin, et al.
The Annals of Pharmacotherapy|August 19, 2003
Baclofen treatment for chronic posttraumatic stress disorderRoger G Drake, Lori L Davis, Marshall E Cates, et al.
Pageof 9